LOGIN  |  REGISTER
C4 Therapeutics

Recent Insider Transactions - Prelude Therapeutics (NASDAQ: PRLD)

Follow NASDAQ:PRLD Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ PRLD Prelude Therapeutics
Huang Jane / officer: President, CMO
04/04/2024
Sell
$4.74
3,347
$16K
51,287
NASDAQ PRLD Prelude Therapeutics
Lim Bryant David / officer: Chief Legal Officer, Corp Sec.
03/01/2024
Buy
$4.59
150,000
$689K
150,000
NASDAQ PRLD Prelude Therapeutics
Scherle Peggy / officer: Chief Scientific Officer
03/01/2024
Buy
$4.59
150,000
$689K
150,000
NASDAQ PRLD Prelude Therapeutics
Combs Andrew / officer: Chief Chemistry Officer
03/01/2024
Buy
$4.59
150,000
$689K
150,000
NASDAQ PRLD Prelude Therapeutics
Chardonnet Laurent / officer: Chief Financial Officer
03/01/2024
Buy
$4.59
150,000
$689K
150,000
NASDAQ PRLD Prelude Therapeutics
Huang Jane / officer: President, CMO
03/01/2024
Buy
$4.59
175,000
$803K
175,000
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
03/01/2024
Buy
$4.59
425,000
$1.951M
425,000
NASDAQ PRLD Prelude Therapeutics
Huang Jane / officer: President, CMO
01/04/2024
Sell
$3.77
3,844
$14K
45,259
NASDAQ PRLD Prelude Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2023
Buy
$0.0001
7.34M
$734
17.97M
NASDAQ PRLD Prelude Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
12/13/2023
Buy
$0.0001
593,452
$59
1.56M
NASDAQ PRLD Prelude Therapeutics
Huang Jane / officer: President, CMO
07/04/2023
Sell
$4.65
3,242
$15K
30,353
NASDAQ PRLD Prelude Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
06/16/2023
Buy
$5.56
23,500
$131K
23,500
NASDAQ PRLD Prelude Therapeutics
Sandor Victor / director
06/16/2023
Buy
$5.56
23,500
$131K
23,500
NASDAQ PRLD Prelude Therapeutics
FRIEDMAN PAUL A / director
06/16/2023
Buy
$5.56
23,500
$131K
23,500
NASDAQ PRLD Prelude Therapeutics
Dier Mardi / director
06/16/2023
Buy
$5.56
23,500
$131K
23,500
NASDAQ PRLD Prelude Therapeutics
Bonita David P / director, 10 percent owner:
06/16/2023
Buy
$5.56
23,500
$131K
23,500
NASDAQ PRLD Prelude Therapeutics
Babler Martin / director
06/16/2023
Buy
$5.56
23,500
$131K
23,500
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
05/25/2023
Buy
$5.31
900
$5K
1.07M
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
05/24/2023
Buy
$5.01
1,000
$5K
1.07M
NASDAQ PRLD Prelude Therapeutics
Lim Bryant David / officer: Chief Legal Officer, Corp Sec.
05/24/2023
Buy
$5.39
2,400
$13K
2,400
NASDAQ PRLD Prelude Therapeutics
Chardonnet Laurent / officer: Chief Financial Officer
05/23/2023
Buy
$5.50
5,000
$28K
42,165
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
05/23/2023
Buy
$5.63
11,856
$67K
1.07M
NASDAQ PRLD Prelude Therapeutics
ORBIMED ADVISORS LLC / director, 10 percent owner:
05/22/2023
Buy
$5.75
869,565
$5.000M
10.12M
NASDAQ PRLD Prelude Therapeutics
Bonita David P / director, 10 percent owner:
05/22/2023
Buy
$5.75
869,565
$5.000M
10.12M
NASDAQ PRLD Prelude Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
05/22/2023
Buy
$0.0001
10.63M
$1K
10.63M
NASDAQ PRLD Prelude Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
05/22/2023
Buy
$0.0001
970,220
$97
970,220
NASDAQ PRLD Prelude Therapeutics
Huang Jane / officer: President, CMO
04/06/2023
Sell
$6.12
13,280
$81K
24,220
NASDAQ PRLD Prelude Therapeutics
Lim Bryant David / officer: Chief Legal Officer, Corp Sec.
03/01/2023
Buy
$5.93
250,000
$1.483M
250,000
NASDAQ PRLD Prelude Therapeutics
Scherle Peggy / officer: Chief Scientific Officer
02/07/2023
Buy
$7.20
135,000
$972K
135,000
NASDAQ PRLD Prelude Therapeutics
Combs Andrew / officer: EVP, Head of Chemistry
02/07/2023
Buy
$7.20
135,000
$972K
135,000
NASDAQ PRLD Prelude Therapeutics
Chardonnet Laurent / officer: Chief Financial Officer
02/07/2023
Buy
$7.20
135,000
$972K
135,000
NASDAQ PRLD Prelude Therapeutics
Huang Jane / officer: President, CMO
02/07/2023
Buy
$7.20
150,000
$1.080M
150,000
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director, officer: CEO
02/07/2023
Buy
$7.20
330,000
$2.376M
330,000
NASDAQ PRLD Prelude Therapeutics
Vaddi Krishna / director: CEO
12/20/2022
Buy
$5.13
19,188
$98K
120,665
NASDAQ PRLD Prelude Therapeutics
Chardonnet Laurent / director: Chief Financial Officer
12/08/2022
Buy
$4.76
10,000
$48K
35,873
NASDAQ PRLD Prelude Therapeutics
Babler Martin / director
06/17/2022
Buy
$4.74
31,293
$148K
31,293
NASDAQ PRLD Prelude Therapeutics
Bonita David P / director, 10 percent owner:
06/17/2022
Buy
$4.74
34,300
$163K
34,300
NASDAQ PRLD Prelude Therapeutics
BAKER BROS. ADVISORS LP / director, 10 percent owner:
06/17/2022
Buy
$4.74
34,300
$163K
34,300
NASDAQ PRLD Prelude Therapeutics
Chardonnet Laurent / director: Chief Financial Officer
06/01/2022
Buy
$4.23
10,000
$42K
24,500

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous